Internal Medicine, Hematology & Oncology · Middleburg, FL
NPI
1033106752
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1658 St Vincents Way Ste 230
Middleburg, FL, 32068
Phone (904) 214-8050
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
105,838 services
Medicare patients, 2024
433
Average age 75
Drug cost, 2024
$3.4M
1,066 prescriptions
Company payments, 2025
$628
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven Siegel was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 9,700 times for 12 patients. In total Steven Siegel billed 105,838 services in 110 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 9,700 | 12 | $2.31 | $22K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,254 | 55 | $0.09 | $196 |
| J0897 Injection, denosumab, 1 mg | Office | 1,980 | 18 | $20.48 | $41K |
| 36415 Venipuncture Blood Collection | Office | 1,310 | 352 | $8.64 | $11K |
| 85025 Blood Count | Office | 1,030 | 318 | $7.55 | $7,775 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 840 | 16 | $0.73 | $612 |
| J1750 Injection, iron dextran, 50 mg | Office | 764 | 25 | $13.44 | $10K |
| 99213 Office E&M - Established | Office | 576 | 272 | $64.96 | $37K |
| 99214 Office E&M - Established | Office | 415 | 143 | $93.98 | $39K |
| 96367 Intravenous Infusion, Hydration | Office | 379 | 53 | $20.62 | $7,815 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 270 | 11 | $0.24 | $65.59 |
| 96413 Chemotherapy Administration | Office | 233 | 40 | $92.89 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 182 | 136 | $12.74 | $2,319 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 167 | 23 | $69.66 | $12K |
| 96415 Chemotherapy Administration | Office | 148 | 21 | $20.76 | $3,072 |
By year: 2022 $2.0M for 115,778 services; 2023 $1.8M for 109,832 services; 2024 $2.1M for 105,838 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,310 | 352 | $8.64 | $11K |
| 85025 Blood Count | 1,030 | 318 | $7.55 | $7,775 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven Siegel prescribed most often to Medicare patients was Eliquis (Apixaban), with 120 prescriptions and refills. In total Steven Siegel wrote 1,066 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 120 | 177 | 27 | $102K |
| Oxycodone Hcl Generic | 72 | 72 | 26 | $1,377 |
| Anastrozole Generic | 54 | 157 | 20 | $901 |
| Xarelto Rivaroxaban | 46 | 81 | Under 11 | $46K |
| Morphine Sulfate Er Morphine Sulfate | 42 | 42 | 11 | $1,277 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 37 | 37 | 13 | $1,428 |
| Methadone Hcl Generic | 32 | 32 | Under 11 | $512 |
| Dexamethasone Generic | 27 | 32 | Under 11 | $222 |
| Lenalidomide Generic | 26 | 26 | Under 11 | $323K |
| Hydromorphone Hcl Generic | 23 | 23 | Under 11 | $1,009 |
| Jakafi Ruxolitinib Phosphate | 23 | 23 | Under 11 | $390K |
| Ibrance Palbociclib | 23 | 23 | Under 11 | $359K |
| Letrozole Generic | 22 | 51 | Under 11 | $429 |
| Hydroxyurea Generic | 18 | 56 | Under 11 | $563 |
| Gabapentin Generic | 18 | 20 | Under 11 | $327 |
Brand drugs: 353 claims; generic drugs: 713 claims; opioid claims: 230.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven Siegel $628 ($628 in general payments such as food, travel and fees) from 23 companies. The largest payer was Novartis Pharmaceuticals Corporation with $95.52.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 6 | $95.52 |
| Daiichi Sankyo Inc. 4568.T | 4 | $89.86 |
| Tempus AI, Inc TEM | 2 | $58.44 |
| Abbvie Inc. ABBV | 4 | $56.26 |
| Array Biopharma Inc PFE | 2 | $27.16 |
| Genzyme Corporation SNY | 1 | $23.83 |
| Novocure Inc. NVCR | 1 | $21.35 |
| Aveo Pharmaceuticals, Inc. | 1 | $20.47 |
| Caris MPI, Inc. | 1 | $19.76 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $19.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.